Full-Time

Director/Senior Director

Field Medical Affairs, Migraine

Confirmed live in the last 24 hours

Axsome Therapeutics Inc

Axsome Therapeutics Inc

201-500 employees

Develops therapies for CNS disorders

Biotechnology
Healthcare

Compensation Overview

$210k - $240kAnnually

+ Bonus + Equity

Senior

New York, NY, USA

Category
Healthcare Administration & Support
Medical, Clinical & Veterinary
Requirements
  • Advanced scientific or clinical degree (D.O, M.D, PharmD, or PhD) is required
  • At least 7 years of experience in a field-based Medical Affairs role
  • At least 2 years of experience leading MSL teams
  • CNS experience required: migraine therapeutic experience strongly preferred
  • Working knowledge of applicable Federal and State guidelines and regulations essential
  • Established relationships with migraine thought leaders highly desirable
  • Ability to work in a dynamic and nimble environment and be solution oriented to changing needs
  • Ability to travel 40% of time, including some weekends
Responsibilities
  • Plan, facilitate, and deliver nonclinical & clinical presentations at Medical Affairs advisory board meetings and/or other meetings that involve HCPs
  • Ensure regular capture and exchange of medical information and insights with other functions as appropriate for Medical Affairs to inform on strategy and unmet medical needs
  • Serve as a technical advisor and represent Medical Affairs at scientific and/or medical meetings, advisory boards, and investigator meetings
  • Establish and maintain a compliant partnership with the commercial team
  • Support/lead various Medical Affairs cross-functional working groups as needed
  • Develop and maintain thought leader relationships
  • Maintain and demonstrate thorough and up-to-date knowledge of disease state, study methodology, clinical information, and product data
  • Manage assigned programs within their designated scope, schedule, and budget
  • Recruit, train, develop and retain a growing, high-performing team of field-based MSLs
  • Ensure individual MSL territory plans and activities for the region align with departmental objectives
  • Establish and oversee collaboration between MSLs to support and optimize communication of key learnings, best practices, and insights generation
  • Identify and implement unmet educational needs for MSL materials
  • Represent MSL team on cross-functional project teams
  • Manage the performance of the individual team members and monitor their overall performance by regularly monitoring their performance against the agreed goals and KPIs
  • Conduct regular performance reviews for individual team members
  • Ensure field compliance of all relevant corporate policies and regulatory guidelines
  • Direct field-based Medical Affairs attendance and coverage at congresses and meetings
  • Ensure operational excellence of the MSL team, including corporate aligned objective/tactics, cross-functional medical support, and interactions with key opinion leaders
  • Participate as a member of the Field Medical Leadership team and assume responsibilities to develop and advance the function
Axsome Therapeutics Inc

Axsome Therapeutics Inc

View

Axsome Therapeutics develops therapies for central nervous system (CNS) disorders, focusing on conditions like major depressive disorder, treatment-resistant depression, and Alzheimer's agitation. Their main product, AXS-05, is an oral medication that works by blocking NMDA receptors in the brain to help regulate mood. This drug has shown positive results in clinical trials and has received FDA Breakthrough Therapy Designation, which helps speed up its approval process. Unlike many competitors, Axsome emphasizes addressing unmet medical needs in CNS disorders and aims to improve patient outcomes through rigorous research and development. The company's goal is to bring effective treatments to market, enhancing the quality of life for patients suffering from these conditions.

Company Stage

IPO

Total Funding

$430.7M

Headquarters

New York City, New York

Founded

2012

Growth & Insights
Headcount

6 month growth

3%

1 year growth

3%

2 year growth

3%
Simplify Jobs

Simplify's Take

What believers are saying

  • Increased investment in Axsome shows strong market confidence in CNS research.
  • Rising demand for personalized medicine offers Axsome opportunities to tailor therapies.
  • Expansion of telemedicine services could boost accessibility to Axsome's treatments.

What critics are saying

  • Increased competition in CNS market from companies like Compass Pathways.
  • Departure of key personnel like Lori Englebert may impact Axsome's market share.
  • Financial pressure to achieve profitability could affect strategic decisions.

What makes Axsome Therapeutics Inc unique

  • Axsome focuses on CNS disorders with limited current treatment options.
  • AXS-05, an NMDA receptor antagonist, has FDA Breakthrough Therapy Designation.
  • Axsome integrates digital therapeutics to enhance CNS treatment offerings.

Help us improve and share your feedback! Did you find this helpful?